Other News To Note

• AVI BioPharma Inc., of Bothell, Wash., said it changed its name to Sarepta Therapeutics Inc. and its stock ticker to "SRPT." The firm also effected a 1-for-6 reverse stock split. The firm is working on RNA-based therapeutics, including lead drug eteplirsen for Duchenne's muscular dystrophy.